Annual CFF
$53.13 M
+$26.66 M+100.74%
01 December 2023
Summary:
OnKure Therapeutics annual cash flow from financing activities is currently $53.13 million, with the most recent change of +$26.66 million (+100.74%) on 01 December 2023.OKUR Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$3.97 M
-$9.84 M-167.60%
30 September 2024
Summary:
OnKure Therapeutics quarterly cash flow from financing activities is currently -$3.97 million, with the most recent change of -$9.84 million (-167.60%) on 30 September 2024. Over the past year, it has dropped by -$15.85 million (-133.37%).OKUR Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$9.96 M
-$15.85 M-268.85%
30 September 2024
Summary:
OnKure Therapeutics TTM cash flow from financing activities is currently -$9.96 million, with the most recent change of -$15.85 million (-268.85%) on 30 September 2024. Over the past year, it has dropped by -$74.95 million (-115.32%).OKUR TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
OKUR Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +100.7% | -133.4% | -115.3% |
| 3 y3 years | - | - | - |
| 5 y5 years | - | - | - |
OKUR Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | at high | -107.5% | -115.3% |
OnKure Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.97 M(-167.6%) | -$9.96 M(-268.8%) |
| June 2024 | - | $5.87 M(>+9900.0%) | $5.90 M(>+9900.0%) |
| Mar 2024 | - | $10.00 K(-100.1%) | $27.00 K(-99.9%) |
| Dec 2023 | - | -$11.87 M | $53.13 M |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2023 | $53.13 M(+100.7%) | - | - |
| Sept 2023 | - | $11.89 M(<-9900.0%) | $64.99 M(+22.4%) |
| June 2023 | - | -$2000.00(-100.0%) | $53.11 M(-0.0%) |
| Mar 2023 | - | $53.11 M | $53.11 M |
| Dec 2022 | $26.46 M | - | - |
FAQ
- What is OnKure Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for OnKure Therapeutics?
- What is OnKure Therapeutics annual CFF year-on-year change?
- What is OnKure Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for OnKure Therapeutics?
- What is OnKure Therapeutics quarterly CFF year-on-year change?
- What is OnKure Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for OnKure Therapeutics?
- What is OnKure Therapeutics TTM CFF year-on-year change?
What is OnKure Therapeutics annual cash flow from financing activities?
The current annual CFF of OKUR is $53.13 M
What is the all time high annual CFF for OnKure Therapeutics?
OnKure Therapeutics all-time high annual cash flow from financing activities is $53.13 M
What is OnKure Therapeutics annual CFF year-on-year change?
Over the past year, OKUR annual cash flow from financing activities has changed by +$26.66 M (+100.74%)
What is OnKure Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of OKUR is -$3.97 M
What is the all time high quarterly CFF for OnKure Therapeutics?
OnKure Therapeutics all-time high quarterly cash flow from financing activities is $53.11 M
What is OnKure Therapeutics quarterly CFF year-on-year change?
Over the past year, OKUR quarterly cash flow from financing activities has changed by -$15.85 M (-133.37%)
What is OnKure Therapeutics TTM cash flow from financing activities?
The current TTM CFF of OKUR is -$9.96 M
What is the all time high TTM CFF for OnKure Therapeutics?
OnKure Therapeutics all-time high TTM cash flow from financing activities is $64.99 M
What is OnKure Therapeutics TTM CFF year-on-year change?
Over the past year, OKUR TTM cash flow from financing activities has changed by -$74.95 M (-115.32%)